まとめ
一般的な薬は肝臓に害を及ぼし,様々な肝臓疾患を模倣する様々な有毒効果を引き起こす可能性があります. 薬物誘発性肝損傷を理解することは,正確な診断と患者のケアに不可欠です.
科学分野:
- 肝臓病理学 肝臓病理学
- 毒理学 毒理学 毒理学
- 薬理学 薬理学とは
背景:
- 薬はしばしば肝臓の損傷と関連しています.
- 薬物誘発性肝損傷 (DILI) は,幅広い臨床的および組織学的特徴を呈することがあります.
- DILIを認識することは,適切な患者管理に不可欠です.
研究 の 目的:
- 薬物誘発性肝損傷の多様な表れをレビューする.
- 肝疾患の微分診断において,薬剤を考慮する重要性を強調する.
主な方法:
- 薬物誘発性肝損傷に関する文献レビュー.
- 肝毒性の臨床および病理学的表現の分析.
主要な成果:
- 薬物の毒性は,代謝産物を通して肝細胞 (肝細胞) に直接ダメージを与える可能性があります.
- 肝毒性は,マイクロベシキュラー脂肪の蓄積,フォスフォリピドーシス,またはウイルス性またはアルコール性肝炎に似た反応として表れます.
- その他の症状には,過敏反応,線維症,コレスタシス,血管性肝臓疾患,肝臓腫瘍などがあります.
結論:
- 薬物誘発性肝損傷は肝疾患の重要な原因である.
- DILIの臨床表現は非常に変動し,実質的にすべての先天性肝疾患を模倣することができます.
- 臨床医は,肝臓異常を有する患者のDILIに対する高い疑い指数を維持する必要があります.
関連する概念動画
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...


